We started out with a blank piece of paper and a big dream to modernize how innovative drugs are developed, to prove that new, branded medicines don’t require high price tags, and to remove the hurdles that stand in the way of patient access to great drugs. So, we’ve been hard at work shaking up the business of drug development.

Here’s what we’ve been doing since our launch one year ago.

What we’ve been up to

  • We’ve gathered a wide range of innovative medicines across disease areas to address treatments with high price tags now and in the future.
  • We’re working to bring late-stage cancer drugs to market in the next few years that could treat some of the most devastating types of cancers.
  • We’re making strides to create new, less expensive therapy combinations through partnerships with biopharma companies to lower overall cost and improve outcomes.
  • We’re reimagining how medicines get to the people who need them, with a focus on removing barriers and improving access to our lower-cost medicines with our strategic partners.
  • We’ve quadrupled the size of our team, making us more than 100 EQRx’ers strong.
  • We’ve raised $750M in just 12 months, proving that the world is ready for this new approach to affordable medicine.

And we’re just getting started.

Subscribe below to stay tuned for all of the EQRx progress to come.